Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Sunil Kumar

Assistant Professor (Pharmaceutical Chemistry)

Chandigarh University

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Collaborators (2)

Saroj Kumar

Associate Professor

All India Institute of Medical Sciences

Manoj Garg

Amity University Noida

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sunil Kumar

Research Interests

Make your next move.

Explore related searches

Articles (15)

Collaborators (2)

Saroj Kumar

Manoj Garg

Make your next move.

Sunil Kumar

Research Interests

Make your next move.

Explore related searches

Articles (15)

Advances in the 1,3,4-oxadiazole-based molecular structures for targeted anticancer therapy: a comprehensive chemical perspective

Carbazole-derived heterocycles as potential leads for modern anticancer drug development

Immunology and biomarkers of COPD

Polycystic ovarian syndrome and infertility

Exploring the hepatoprotective and cytotoxic activities of Thalictrum foliolosum and Cordia dichotoma for targeting acute liver injury

Investigating the anti-inflammatory potential of Eleusine coracana (L.) Gaertn. Seeds on LPS-induced RAW264.7 cell line with in-silico analysis

Recent advances in imidazole-hybrid pharmacophores for anti-cancer applications

Exploring the role of plants as neuroprotectant and its mode of action

In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer

In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer

In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies

Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer

In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer

Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer

Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy

Collaborators (2)

Saroj Kumar

Manoj Garg

Make your next move.